A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
about
Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinomaMicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass indexO(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitionsA KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotypeDNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in SW48 and HT-29 colorectal cancer cellsAberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinomaCysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer.Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancerAlcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiationRelation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas.O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer.Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling.MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular featuresGenetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instabilityMeta-analysis of the association between APC promoter methylation and colorectal cancer.Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans.Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis.Hypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression.The blues of P(16)INK(4a): aberrant promoter methylation and association with colorectal cancer in the Kashmir valley.Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients.Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population.Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinomaAlkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteinsEpigenetic aberrations and cancer.Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinomaEpigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survivalColorectal cancer: molecular mutations and polymorphisms.Therapeutic targets in the ARF tumor suppressor pathway.DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancerMolecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screeningExpression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.
P2860
Q24307851-6ACEF179-31FD-4FED-9A55-DBB23C564D05Q24628888-9DBC960B-BD72-48F3-8DC5-CEACDB3E1684Q24685624-B8B96415-165A-4909-8F04-3530152AF526Q28117127-3839C9FB-67BE-46A3-90B5-F08BC173B85EQ28541605-11B27B24-69F3-4DA2-B0F1-D3668B64D9EAQ30506094-CCE9419B-55C9-4801-A39F-A545ED0A58E8Q31101539-80771B8F-16F2-4790-A801-C11CFDEC2753Q33491520-2D66D875-5D36-412E-AC74-07F5DC020F16Q33729779-BF9FF988-8990-483D-ABEA-25C40BB8052BQ33826788-63E23BE6-4412-4ACE-A5CB-6E277AEAC5BBQ34110040-8E6EA488-8D6A-4E96-A044-1BCA5B5B31CCQ34227653-853DDE75-21EA-4494-B932-17DB02461FEDQ34334482-FD9FA92B-25BE-4F8F-AEC7-2C86CB257E97Q34335025-857E86B3-3948-4973-BDD2-910727B402B2Q34362828-15D695A2-8D3E-413A-BE2D-FB4FB966F76BQ34500702-99AC7420-2F1B-47BB-83F2-5AD1ABF25793Q34650716-1FB4772D-EA24-4828-B808-80131881272CQ34768295-79328AC7-A287-4DDF-B098-5369364E8BB7Q35006439-C3E7280A-F6F5-4E71-8A9E-E8A1C47CC715Q35550260-6009B817-BC93-40D5-91A7-1C26790E7868Q35586979-85384AE1-10F3-4F7E-9863-AC078ACF1EF3Q35790060-E0192AB2-C862-416C-AEB4-04C0FD9249DEQ35886573-23BEC833-CFA3-41DE-B861-DEF0501BC27EQ35897271-CEFAB673-FADB-44FD-BAE2-DEAFB84927A4Q35964783-A17B0F32-592E-4B65-9F2F-3A7B6A9327CEQ36316169-F6FB8617-5878-48AF-A101-C94C96BFDBF7Q36383337-A1B05CCE-167A-420D-AD17-5D0DA1F63FA8Q36475438-C86F0275-353B-4625-BE0F-0F1A5DADA5F8Q36477008-AD08FFF2-F7A5-4475-B1B0-DD70C63AFF50Q36529734-3967461F-5E35-4346-87FD-1778E653FB40Q36570190-5BD33A06-B58A-4365-95DA-ADFBFE49FD3DQ36648081-4D0B1086-1AD8-4646-91FB-11A8CBD01A12Q36694634-93FF0080-B01D-462C-A546-B983658C64CBQ36746000-EA2AB5DC-92C1-40F3-B844-2B8F377D245EQ36837622-63EB07F0-7CD2-4DE9-83E5-FF9E5BD80953Q36879301-875097C4-C26C-44CA-B587-9771033C41D7Q37055333-2EFE6E08-48D6-42EF-8859-CE1969735D12Q37066133-7E8017AA-3B50-4486-910F-04478213BF2BQ37071371-A69ADFE8-1603-45B6-9967-6C6001BD41DAQ37091263-DD649BE5-BBCE-4E0F-98D3-399177EF9C22
P2860
A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A CpG island hypermethylation ...... as and colon cancer cell lines
@ast
A CpG island hypermethylation ...... as and colon cancer cell lines
@en
A CpG island hypermethylation ...... as and colon cancer cell lines
@nl
type
label
A CpG island hypermethylation ...... as and colon cancer cell lines
@ast
A CpG island hypermethylation ...... as and colon cancer cell lines
@en
A CpG island hypermethylation ...... as and colon cancer cell lines
@nl
prefLabel
A CpG island hypermethylation ...... as and colon cancer cell lines
@ast
A CpG island hypermethylation ...... as and colon cancer cell lines
@en
A CpG island hypermethylation ...... as and colon cancer cell lines
@nl
P2093
P2860
P3181
P356
P1433
P1476
A CpG island hypermethylation ...... as and colon cancer cell lines
@en
P2093
Gunn I Meling
Guro E Lind
Lin Thorstensen
Richard Hamelin
Tone Løvig
Torleiv O Rognum
P2860
P2888
P3181
P356
10.1186/1476-4598-3-28
P407
P577
2004-10-11T00:00:00Z
P5875
P6179
1040177135